These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 6348763

  • 21. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

  • 22. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
    Bailey RR.
    N Z Med J; 1989 Jul 26; 102(872):379-81. PubMed ID: 2797556
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May 26; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 24. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up.
    Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA.
    Clin Nephrol; 1995 Feb 26; 43(2):84-8. PubMed ID: 7736683
    [Abstract] [Full Text] [Related]

  • 25. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul 26; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 26. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
    Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R.
    J Am Soc Nephrol; 1998 Mar 26; 9(3):444-50. PubMed ID: 9513907
    [Abstract] [Full Text] [Related]

  • 27. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
    Ardiles LG, Mezzano SA.
    Clin Nephrol; 1996 Jun 26; 45(6):423. PubMed ID: 8793243
    [No Abstract] [Full Text] [Related]

  • 28. Membranous nephropathy--still a treatment dilemma.
    Cameron JS.
    N Engl J Med; 1992 Aug 27; 327(9):638-9. PubMed ID: 1640957
    [No Abstract] [Full Text] [Related]

  • 29. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party.
    Cameron JS, Healy MJ, Adu D.
    Q J Med; 1990 Feb 27; 74(274):133-56. PubMed ID: 2189149
    [Abstract] [Full Text] [Related]

  • 30. Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure.
    Warwick GL, Geddes CG, Boulton-Jones JM.
    Q J Med; 1994 Apr 27; 87(4):223-9. PubMed ID: 8208913
    [Abstract] [Full Text] [Related]

  • 31. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.
    Chin Med J (Engl); 2001 Dec 27; 114(12):1305-8. PubMed ID: 11793859
    [Abstract] [Full Text] [Related]

  • 32. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug 27; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 33. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989 Aug 27; 46(12):816-21. PubMed ID: 2698488
    [No Abstract] [Full Text] [Related]

  • 34. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
    Opastirakul S, Chartapisak W.
    J Med Assoc Thai; 2006 Dec 27; 89(12):2145-9. PubMed ID: 17214070
    [Abstract] [Full Text] [Related]

  • 35. Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome.
    Hari P, Bagga A, Mantan M.
    Indian Pediatr; 2004 Oct 27; 41(10):993-1000. PubMed ID: 15523124
    [Abstract] [Full Text] [Related]

  • 36. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 27; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 37. Effective treatment administration of cyclophosphamide in membranous nephropathy.
    Dede F, Ayili D, Sahiner S.
    J Nephrol; 2008 Nov 27; 21(4):560-5. PubMed ID: 18651546
    [Abstract] [Full Text] [Related]

  • 38. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V.
    J Am Soc Nephrol; 2007 Jun 27; 18(6):1899-904. PubMed ID: 17494881
    [Abstract] [Full Text] [Related]

  • 39. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Jun 27; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 40. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct 27; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.